Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes
Open Access
- 11 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (6), 1016-1019
- https://doi.org/10.1093/jac/dki140
Abstract
Objectives: The effect of different media and composition on the in vitro activity of posaconazole, caspofungin and voriconazole against 59 zygomycetes species was determined. Methods: The media tested were RPMI 1640 medium with and without 2% glucose, antibiotic medium 3 (AM3) with and without 2% glucose, and high resolution (HR) medium. Results: Posaconazole was significantly more active than caspofungin and voriconazole, both in RPMI 1640 medium with 2% glucose and in HR medium. Adding glucose improved the determination of end points, but had only minor influence on the MICs. MICs evaluated in AM3 were lower than in RPMI 1640 medium or HR medium. Conclusions: The in vivo effect of posaconazole in zygomycosis needs further evaluation.Keywords
This publication has 10 references indexed in Scilit:
- Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infectionsInternational Journal Of Clinical Practice, 2004
- Activity of Posaconazole in Treatment of Experimental Disseminated ZygomycosisAntimicrobial Agents and Chemotherapy, 2003
- Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2003
- Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different mediaJournal of Antimicrobial Chemotherapy, 2003
- In vitro susceptibilities of zygomycetes to conventional and new antifungalsJournal of Antimicrobial Chemotherapy, 2002
- In Vivo Activity of Posaconazole againstMucorspp. in an Immunosuppressed-Mouse ModelAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of ZygomycetesAntimicrobial Agents and Chemotherapy, 2002
- Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensisJournal of Antimicrobial Chemotherapy, 2001
- Detection of amphotericin B-resistant Candida isolates in a broth-based systemAntimicrobial Agents and Chemotherapy, 1995
- Antigenic characterization of some potentially pathogenic mucoraceous fungiMedical Mycology, 1982